Imaging Biometrics

08/15/2025

Dr. Max Krucoff’s use of Delta T1 maps to assess ablation extent after LITT is a powerful example of how the objective, quantitative imaging of Delta T1 maps can elevate clinical decision-making and confidence.

Unlike conventional image (like T1+C) that rely on subjective interpretation, Delta T1 maps remove ambiguity—delivering reproducible insights that support better outcomes.

Proud to see Imaging Biometrics’ technology helping clinicians push the boundaries of neuro-oncology!

06/05/2025

Great work MCW!

Chasing Chad recently met with several doctors from the Medical College of Wisconsin to hear updates on all the great work they are doing for brain tumor patients: Gallium Maltolate (GaM) trial, Pulsed Lose Dose Radiation (PLDR) trial, researching and mapping brain functions for better surgical outcomes and creating a neuro-oncology fellowship. Thank you Drs. Connelly, Straza and Krucoff for all that you do!

11/13/2024

https://x.com/IQAI_IB/status/1856717329742114938

03/18/2024

Sign up for our upcoming Webinar on Accurate DSC-MRI Acquisition on April 16, 11AM, CDT!

03/11/2024

Check out our March Newsletter!
https://mailchi.mp/imagingbiometrics/ib-newsletter-edition-17708575

03/06/2024

We're looking forward to this upcoming event with industry leaders!

Implementing Diverse Mechanisms Across Improved Clinical Translation to Develop Safe, Effective & Deliverable Glioblastoma Therapies

02/28/2024

While a small study, advanced imaging proves important to Tumor Treating Fields.

AbstractBACKGROUND. Tumor-treating fields (TTFields) is a novel US FDA-approved antimitotic treatment modality for patients with newly diagnosed and recurrent g

02/22/2024

"The utility of dT1 maps! Decreased RTV, correlates with improved OS in patients with GBM, a simple and objective means by which surgical outcomes can be routinely assessed."

response, the objective of this study is to evaluate the clinical efficacy of an easy-to-use MRI metric, called delta T1 (dT1), to quantify the extent of resection (EOR) and RTV, in comparison with radiologist impression, to predict overall survival (OS) in patients with glioblastoma. METHODS: Fifty...

02/12/2024

Here's a good research article describing the effects of Gallium Maltolate, for more information about the Expanded Access Program, or to sign up please fill out the form on our website:

01/31/2024

Watch yesterday's Webinar to learn how IB Nimble, a mobile app, improves Healthcare outcomes!

Dr. Joe Bovi shares the current landscape of algorithmic medicine, the history of the IB Nimble application (the handheld mobile device that enables multi-di...